A decline in glomerular filtration rate rather than renal arterial stenotic lesions, per se, predicts cardiovascular-renal events in type 2 diabetic patients

Circulation Journal

Volumn 77, Issue 11, 2013, Pages 2816-2822

  Ogawa, Susumu ^a,b   Nako, Kazuhiro ^a   Okamura, Masashi ^a   Senda, Miho ^a   Sakamoto, Takuya ^a   Abe, Takaaki ^b,c   Ito, Sadayoshi ^a  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiopoietin 2; Cardiovascular renal event; Estimated glomerular filtration rate; Ischemic renal injury; Renal artery arteriosclerosis

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ANGIOPOIETIN 2; BRAIN NATRIURETIC PEPTIDE; GADOLINIUM; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; GLOMERULUS FILTRATION RATE; HEART DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; LONGITUDINAL STUDY; MAGNETIC RESONANCE ANGIOGRAPHY; NEPHROSCLEROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PULSE WAVE; SYSTOLIC BLOOD PRESSURE;

ATHEROSCLEROSIS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; RENAL ARTERY OBSTRUCTION;

EID: 84886523330     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-0269     Document Type: Article

References (32)

1. Saito I. Epidemiological evidence of type 2 diabetes mellitus, metabolic syndrome, and cardiovascular disease in Japan. Circ J 2012; 76: 1066-1073.
2. Manabe I. Chronic inflammation links cardiovascular, metabolic and renal diseases. Circ J 2011; 75: 2739-2748.
3. Duda SH, Schick F, Teufl F, Müller-Schimpfle M, Erley C, Schneider W, et al. Phase-contrast MR angiography for detection of arteriosclerotic renal artery stenosis. Acta Radiol 1997; 38: 287-291.
4. Vasbinder GB, Nelemans PJ, Kessels AG, Kroon AA, de Leeuw PW, van Engelshoven JM. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: A metaanalysis. Ann Intern Med 2001; 135: 401-411.
5. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113: e463-e654. http://www.ncbi.nlm.nih.gov/pubmed/16549646 (accessed March 21 2006).
6. Dzielińska Z, Januszewicz A, Demkow M, Makowiecka-Cieśla M, Prejbisz A, Naruszewicz M, et al. Cardiovascular risk factors in hypertensive patients with coronary artery disease and coexisting renal artery stenosis. J Hypertens 2007; 25: 663-670.
7. Webster J, Marshall F, Abdalla M, Dominiczak A, Edwards R, Isles CG, et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis: Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998; 12: 329-335.
8. van Jaarsveld BC, Krijnen P, Pieterman H, Derkx FH, Deinum J, Postma CT, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis: Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000; 342: 1007-1014.
9. Tanemoto M, Saitoh H, Satoh F, Satoh H, Abe T, Ito S. Predictors of undiagnosed renal artery stenosis among Japanese patients with risk factors of atherosclerosis. Hypertens Res 2005; 28: 237-242.
10. Pearce JD, Craven BL, Craven TE, Piercy KT, Stafford JM, Edwards MS, et al. Progression of atherosclerotic renovascular disease: A prospective population-based study. J Vasc Surg 2006; 44: 955-962.
11. Cheung CM, Wright JR, Shurrab AE, Mamtora H, Foley RN, O'Donoghue DJ, et al. Epidemiology of renal dysfunction and patient outcome in atherosclerotic renal artery occlusion. J Am Soc Nephrol 2002; 13: 149-157.
12. Wright JR, Shurrab AE, Cheung C, Waldek S, O'Donoghue DJ, Foley RN, et al. A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. Am J Kidney Dis 2002; 39: 1153-1161.
13. Cohen MG, Pascua JA, Garcia-Ben M, Rojas-Matas CA, Gabay JM, Berrocal DH, et al. A simple prediction rule for significant renal artery stenosis in patients undergoing cardiac catheterization. Am Heart J 2005; 150: 1204-1211.
14. Nakamura S, Iihara K, Matayoshi T, Yasuda H, Yoshihara F, Kamide K, et al. The incidence and risk factors of renal artery stenosis in patients with severe carotid artery stenosis. Hypertens Res 2007; 30: 839-844.
15. Patel JV, Lim HS, Varughese GI, Hughes EA, Lip GY. Angiopoietin- 2 levels as a biomarker of cardiovascular risk in patients with hypertension. Ann Med 2008; 40: 215-222.
16. Harding MB, Smith LR, Himmelstein SI, Harrison K, Phillips HR, Schwab SJ, et al. Renal artery stenosis: Prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol 1992; 2: 1608-1616.
17. Uzu T, Inoue T, Fujii T, Nakamura S, Inenaga T, Yutani C, et al. Prevalence and predictors of renal artery stenosis in patients with myocardial infarction. Am J Kidney Dis 1997; 29: 733-738.
18. Yamashita T, Ito F, Iwakiri N, Mitsuyama H, Fujii S, Kitabatake A. Prevalence and predictors of renal artery stenosis in patients undergoing cardiac catheterization. Hypertens Res 2002; 25: 553-557.
19. Wright JR, Shurrab AE, Cooper A, Kalra PR, Foley RN, Kalra PA. Progression of cardiac dysfunction in patients with atherosclerotic renovascular disease. QJM 2009; 102: 695-704.
20. Uzu T, Takeji M, Yamada N, Fujii T, Yamauchi A, Takishita S, et al. Prevalence and outcome of renal artery stenosis in atherosclerotic patients with renal dysfunction. Hypertens Res 2002; 25: 537-542.
21. Caps MT, Perissinotto C, Zierler RE, Polissar NL, Bergelin RO, Tullis MJ, et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998; 98: 2866-2872.
22. Caps MT, Zierler RE, Polissar NL, Bergelin RO, Beach KW, Cantwell-Gab K, et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int 1998; 53: 735-742.
23. Lim HS, Blann AD, Chong AY, Freestone B, Lip GY. Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: Implications for cardiovascular risk and effects of multifactorial intervention. Diabetes Care 2004; 27: 2918-2924.
24. David S, John SG, Jefferies HJ, Sigrist MK, Kümpers P, Kielstein JT, et al. Angiopoietin-2 levels predict mortality in CKD patients. Nephrol Dial Transplant 2012; 27: 1867-1872.
25. Golledge J, Clancy P, Yeap BB, Hankey GJ, Norman PE. Increased serum angiopoietin-2 is associated with abdominal aortic aneurysm prevalence and cardiovascular mortality in older men. Int J Cardiol 2012 April 4, doi:10.1016/j.ijcard.2012.03.120 [Epub ahead of print].
26. Chen J, Yu H, Sun K, Song W, Bai Y, Yang T, et al. Promoter variant of angiopoietin-2 and plasma angiopoietin-2 are associated with risk of stroke recurrence in lacunar infarct patients. Biochem Biophys Res Commun 2010; 398: 212-216.
27. Nadar SK, Blann A, Beevers DG, Lip GY. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: Relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)]. J Intern Med 2005; 258: 336-343.
28. Apple FS, Wu AH, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trials. Am Heart J 2002; 144: 981-986.
29. Crespi V, Braga M, Beretta S, Carolei A, Bignamini A, Sacco S. A practical definition of minor stroke. Neurol Sci 2013; 34: 1083-1086.
30. Ogawa S, Nakayama K, Nakayama M, Mori T, Matsushima M, Okamura M, et al. Methylglyoxal is a predictor in type 2 diabetic patients of intima-media thickening and elevation of blood pressure. Hypertension 2010; 56: 471-476.
31. Temelkova-Kurktschiev TS, Koehler C, Leonhardt W, Schaper F, Henkel E, Siegert G, et al. Increased intimal-medial thickness in newly detected type 2 diabetes: Risk factors. Diabetes Care 1999; 22: 333-338.
32. Yamashina A, Tomiyama H, Arai T, Hirose K, Koji Y, Hirayama Y, et al. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res 2003; 26: 615-622.